Tomohiro Umeda

1.5k total citations
31 papers, 1.2k citations indexed

About

Tomohiro Umeda is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Tomohiro Umeda has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Tomohiro Umeda's work include Alzheimer's disease research and treatments (22 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Prion Diseases and Protein Misfolding (4 papers). Tomohiro Umeda is often cited by papers focused on Alzheimer's disease research and treatments (22 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Prion Diseases and Protein Misfolding (4 papers). Tomohiro Umeda collaborates with scholars based in Japan, United States and Bulgaria. Tomohiro Umeda's co-authors include Takami Tomiyama, Hiroshi Mori, William L. Klein, Mary P. Lambert, Kiyouhisa Ohnishi, Hiroshi Takuma, Takenari Yamashita, Shogo Matsuyama, Kenichi Ishibashi and Kazuhiro Ito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Brain.

In The Last Decade

Tomohiro Umeda

30 papers receiving 1.2k citations

Peers

Countries citing papers authored by Tomohiro Umeda

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Umeda more than expected).

Fields of papers citing papers by Tomohiro Umeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Umeda. The network helps show where Tomohiro Umeda may publish in the future.

Co-authorship network of co-authors of Tomohiro Umeda

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Umeda. A scholar is included among the top collaborators of Tomohiro Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Umeda. Tomohiro Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New Value of Acorus tatarinowii/gramineus Leaves as a Dietary Source for Dementia Prevention 2024 ·Nutrients ·Tomohiro Umeda, (unknown), (unknown), (unknown), (unknown), Kei Yamana, Takami Tomiyama	3
2	The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice 2024 ·Brain Research ·Chia-Jung Chang, Zacharie Taoufiq, Hiroshi Yamada, Kohji Takei, Takami Tomiyama, Tomohiro Umeda, Tetsuya Hori, Tomoyuki Takahashi	2
3	Investigating the efficacy of nasal administration for delivering magnetic nanoparticles into the brain for magnetic particle imaging 2024 ·Journal of Controlled Release ·Satoshi Seino, (unknown), (unknown), Tomohiro Umeda, Takami Tomiyama, (unknown), Tomoyuki Furubayashi, Toshiyasu Sakane, Toshihiko Kiwa, (unknown), (unknown), (unknown), (unknown), Yuki Okumura, Takashi Nakagawa	10
4	Simply crushed zizyphi spinosi semen prevents neurodegenerative diseases and reverses age-related cognitive decline in mice 2024 ·eLife ·Tomohiro Umeda, (unknown), (unknown), (unknown), (unknown), Kei Yamana, Takami Tomiyama	0
5	Hawaiian native herb Mamaki prevents dementia by ameliorating neuropathology and repairing neurons in four different mouse models of neurodegenerative diseases 2023 ·GeroScience ·Tomohiro Umeda, (unknown), (unknown), Kazunori Matsuda, Takami Tomiyama	2
6	C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice 2022 ·Biomedicines ·(unknown), Tomohiro Umeda, (unknown), (unknown), Yoshitaka Nagai, Takami Tomiyama	3
7	Peripheral Aβ acts as a negative modulator of insulin secretion 2022 ·Proceedings of the National Academy of Sciences ·(unknown), Sachiko Nomura, Tomohiro Umeda, Shuko Takeda, Takami Tomiyama	9
8	Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice 2021 ·Frontiers in Neuroscience ·Tomohiro Umeda, (unknown), (unknown), (unknown), Toru Kumagai, Takami Tomiyama	21
9	Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers 2021 ·International Journal of Molecular Sciences ·Tomohiro Umeda, (unknown), (unknown), Takami Tomiyama	14
10	Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice 2017 ·Acta Neuropathologica Communications ·Tomohiro Umeda, Tetsuya Kimura, Kayo Yoshida, Keizo Takao, Yuki Fujita, Shogo Matsuyama, (unknown), M. Yamashita, Yūki Yamashita, Kiyouhisa Ohnishi, (unknown), Hiroshi Takuma, Tsuyoshi Miyakawa, Akihiko Takashima, Takashi Morita, Hiroshi Mori, Takami Tomiyama	21
11	Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers 2016 ·Brain ·Tomohiro Umeda, Kenjiro Ono, (unknown), M. Yamashita, Mineyuki Mizuguchi, William L. Klein, Masahito Yamada, Hiroshi Mori, Takami Tomiyama	100
12	Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons 2015 ·Acta Neuropathologica Communications ·Tomohiro Umeda, (unknown), M. Yamashita, Koichi Nakajima, Hiroshi Mori, Michael Silverman, Takami Tomiyama	49
13	Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice 2014 ·Acta Neuropathologica ·Tomohiro Umeda, Satomi Maekawa, Tetsuya Kimura, Akihiko Takashima, Takami Tomiyama, Hiroshi Mori	55
14	Neurodegenerative Disorder FTDP-17–Related Tau Intron 10 +16C→T Mutation Increases Tau Exon 10 Splicing and Causes Tauopathy in Transgenic Mice 2013 ·American Journal Of Pathology ·Tomohiro Umeda, Takenari Yamashita, Tetsuya Kimura, Kiyouhisa Ohnishi, Hiroshi Takuma, (unknown), Akihiko Takashima, Takami Tomiyama, Hiroshi Mori	35
15	Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice 2012 ·Life Sciences ·Tomohiro Umeda, Takami Tomiyama, (unknown), (unknown), Sachiko Nomura, Mary P. Lambert, William L. Klein, Hiroshi Mori	63
16	P3‐134: Intraneuronal amyloid‐beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo 2011 ·Alzheimer s & Dementia ·Tomohiro Umeda, Takami Tomiyama, (unknown), (unknown), Mary P. Lambert, William L. Klein, Hiroshi Mori	39
17	Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo 2011 ·Journal of Neuroscience Research ·Tomohiro Umeda, Takami Tomiyama, (unknown), (unknown), Mary P. Lambert, William L. Klein, Hiroshi Mori	220
18	Regulation of cholesterol efflux by amyloid β secretion 2010 ·Journal of Neuroscience Research ·Tomohiro Umeda, Hiroshi Mori, Hui Zheng, Takami Tomiyama	25
19	A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo 2010 ·Journal of Neuroscience ·Takami Tomiyama, Shogo Matsuyama, Hiroyuki Iso, Tomohiro Umeda, Hiroshi Takuma, Kiyouhisa Ohnishi, Kenichi Ishibashi, Rie Teraoka, (unknown), Takenari Yamashita, Kazuchika Nishitsuji, Kazuhiro Ito, Hiroyuki Shimada, Mary P. Lambert, William L. Klein, Hiroshi Mori	326
20	Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form 2009 ·Current Alzheimer Research ·Kazuhiro Ito, Kenichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Keiichi Yamamoto, (unknown), (unknown), (unknown), Hiroshi Mori	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact